NUBEQA (darolutimide) as MONOTHERAPY ... - Advanced Prostate...

Advanced Prostate Cancer

20,993 members26,166 posts

NUBEQA (darolutimide) as MONOTHERAPY (no lupron or similar)?

Gl448 profile image
11 Replies

I’ve seen two posts today in a couple of threads stating that they’re currently on NUBEQA, or will soon be as a monotherapy without first line ADT like casodex or Lupron.

One gent says after 7 months he’s got testosterone levels of 700 with undetectable PSA and no progression on scans.

Another says he’s going off the casodex soon for NUBEQA.

Not sure yet if they’re talking about holidays or more. Anyone else out there on similar protocol?

I’d sure like to hear more about this, and any studies supporting this. Dumping Lupron would be a fantastic improvement in QOL…

Written by
Gl448 profile image
Gl448
To view profiles and participate in discussions please or .
Read more about...
11 Replies
Tall_Allen profile image
Tall_Allen

I'm not sure that it improves the QOL or works as well. But that is what the European trial will determine:

clinicaltrials.gov/ct2/show...

Nubeqa potently blocks the androgen receptor, so testosterone, having nowhere to go, accumulates in the serum. I expect that, like Casodex monotherapy, it causes gynecomastia , baldness, and fatigue, but worse than Casodex, as enzalutamide monotherapy did:

thelancet.com/journals/lano...

Similar trials have been run for monotherapy with abiraterone.

nature.com/articles/s41391-...

Apalutamide monotherapy was inferior to ADT+abiraterone:

ejcancer.com/article/S0959-...

Gl448 profile image
Gl448 in reply to Tall_Allen

Great information. I assumed you'd lose the low-testosterone effects of Lupron.

Thanks, as always!

Trivista profile image
Trivista

Iam on Lupron and will be for life. And I have also added Nbequa 14 months ago.

Gleason 9. RP 2015.

PSA was rising even on Lupron. Trend was not my friend. So Doctor at Dana Farber prescribed Nubequa after a PSMA scan was negative. PSA slowly dropped. VA Paid for Nubequa as I am 100% service connected. Trend is now down.

JolleySprings profile image
JolleySprings in reply to Trivista

How quickly did your PSA drop once you started NUBEQA??

Trivista profile image
Trivista in reply to JolleySprings

It was down in 3 moths and continues to trend lower every 3 months with each blood test. It has gone from 1.7 to .19 in a year. thw 1.7 reading was a doubling move in 2021. With a Gleason 9 I didn't take any chances. I wasn't interested in monitoring it as it climbed higher. So, the trend is my friend right now.

tarhoosier profile image
tarhoosier

I have been on Enzalutamide monotherapy for 6.5 years. Gynecomastia is moderate and other side effects are minor or associated with ageing. Oncologist suggested it as zoladex was not a problem. I can resume Zoladex/degarelix at any time if psa requires.

GP24 profile image
GP24 in reply to tarhoosier

The Embark trial results will be published this year. This tested enzalutamide monotherapy versus enza + lupron.

Derf4223 profile image
Derf4223 in reply to GP24

EMBARK is studying non-metastatic patients. With every trial, please look to inclusion criteria first to gauge relevance to this group.

j-o-h-n profile image
j-o-h-n

Went off casodex in late January 2023 and starting nubeqUa tomorrow, Thursday, 03/09/2023. As far as I know I will still be on Lupron......

Good Luck, Good Health and Good Humor.

j-o-h-n Wednesday 03/09/2023 6:45 PM EST

JolleySprings profile image
JolleySprings in reply to j-o-h-n

How is the Nubequa working for you??

j-o-h-n profile image
j-o-h-n in reply to JolleySprings

Only side effects are that I'm tired (sleeping more) and shortness of breath....Cardiologist is checking the shortness of breath but I'm sure he won't let me run out before all my bills are paid.....

Good Luck, Good Health and Good Humor.

j-o-h-n Sunday 08/13/2023 1:08 PM EST

You may also like...

Nubeqa monotherapy update

in to my experiment with Nubeqa monotherapy, and so far, so good. Latest PSA saw a slight increase...

Darolutimide as monotherapy

very effective in lowering PSA. Since it doesn't actually stop testosterone production but instead...

Nubeqa monotherapy experiment coming to end

9 months of Nubeqa as a monotherapy, the Nubeqa alone is not going to keep PSA at bay. PSA has...

Nubeqa (Darolutimide) mono-therapy update

encouraging. After being on a nice drug holiday for the past year, PSA was starting to rise again...

Nubeqa monotherapy update

The first month of Nubeqa (darolutimide) monotherapy resulted in a PSA drop from 5.0 to 1.6 . I just